Abstract
Schizophrenia is a severe chronic debilitating disorder with millions of affected individuals. Diagnosis is based on clinical presentations, which are made when the progressive disease has appeared. Early diagnosis may help improve the clinical outcomes and response to treatments. Lack of a reliable molecular diagnostic invokes the identification of novel biomarkers. To elucidate the molecular basis of the disease, in this study we used two mRNA expression arrays, including GSE93987 and GSE38485, and one miRNA array, GSE54914, and meta-analysis was conducted for evaluation of mRNA expression arrays via metaDE package. Using WGCNA package, we performed network analysis for both mRNA expression arrays separately. Then, we constructed protein–protein interaction network for significant modules. Limma package was employed to analyze the miRNA array for identification of dysregulated miRNAs (DEMs). Using genes of significant modules and DEMs, a mRNA-miRNA network was constructed and hub genes and miRNAs were identified. To confirm the dysregulated genes, expression values were evaluated through available datasets including GSE62333, GSE93987, and GSE38485. The ability of the detected hub miRNAs to discriminate schizophrenia from healthy controls was evaluated by assessing the receiver-operating curve. Finally, the expression levels of genes and miRNAs were evaluated in 40 schizophrenia patients compared with healthy controls via Real-Time PCR. The results confirmed dysregulation of hsa-miR-574-5P, hsa-miR-1827, hsa-miR-4429, CREBRF, ARPP19, TGFBR2, and YWHAZ in blood samples of schizophrenia patients. In conclusion, three miRNAs including hsa-miR-574-5P, hsa-miR-1827, and hsa-miR-4429 are suggested as potential biomarkers for diagnosis of schizophrenia.
Graphic Abstract
Similar content being viewed by others
Availability of Data and Materials
The data used to support the findings of this study are available from the corresponding author upon request.
References
Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005
Bassett AS, Chow EW, Weksberg R, Brzustowicz L (2002) Schizophrenia and genetics: new insights. Curr Psychiatry Rep 4(4):307–314
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A et al (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25(8):1091–1093
Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23(1):175–205
Cui Z, Tang J, Chen J, Wang Z (2014) Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis. Cancer Cell Int 14(1):1–9
Dong R, Shen Z, Zheng C, Chen G, Zheng S (2016) Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia. Sci Rep 6:21084
Donzelli J, Proestler E, Riedel A, Nevermann S, Hertel B, Guenther A et al (2021) Small extracellular vesicle-derived miR-574–5p regulates PGE2-biosynthesis via TLR7/8 in lung cancer. J Extracell Vesicles 10(12):e12143-e
Du Y, Tan WL, Chen L, Yang ZM, Li XS, Xue X et al (2021) Exosome transplantation from patients with schizophrenia causes schizophrenia-relevant behaviors in mice: an integrative multi-omics data analysis. Schizophr Bull 47(5):1288–1299
Du Y, Yu Y, Hu Y, Li XW, Wei ZX, Pan RY et al (2019) Genome-wide, integrative analysis implicates exosome-derived MicroRNA dysregulation in schizophrenia. Schizophr Bull 45(6):1257–1266
Feltrin ASA, Tahira AC, Simões SN, Brentani H, Martins DC Jr (2019) Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders. PLoS One 14(1):e0210431-e
Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6(3):482–488
Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ (2007) miRBase: tools for microRNA genomics. Nucleic Acids Res 36(suppl_1):D154-D158
Guo X, Wang Z, Sun Q, Sun C, Hua H, Huang Q (2020) The inhibitory effect of microRNA-1827 on anoikis resistance in lung adenocarcinoma A549 cells via targeting caveolin-1. Acta Biochim Biophys Sin 52(10):1148–1155
Guo H, Yan Z, Hu Y, Huang X, Pan C (2021) Complement C7 is specifically expressed in mesangial cells and is a potential diagnostic biomarker for diabetic nephropathy and is regulated by miR-494-3p and miR-574-5p. Diabetes Metab Syndr Obes 14:3077–3088
Hauberg ME, Roussos P, Grove J, Børglum AD, Mattheisen M, Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) Analyzing the role of MicroRNAs in schizophrenia in the context of common genetic risk variants. JAMA Psychiat 73(4):369–377
He K, Guo C, He L, Shi Y (2017) MiRNAs of peripheral blood as the biomarker of schizophrenia. Hereditas 155(1):9
Hegewald AB, Breitwieser K, Ottinger SM, Mobarrez F, Korotkova M, Rethi B et al (2020) Extracellular miR-574–5p induces osteoclast differentiation via TLR 7/8 in rheumatoid arthritis. Front Immunol 11:585282
Islam MS, Khan MA, Murad MW, Karim M, Islam AB (2019) In silico analysis revealed Zika virus miRNAs associated with viral pathogenesis through alteration of host genes involved in immune response and neurological functions. J Medic Virol 91(9):1584–1594
James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 392(10159):1789–1858
Jickling GC, Ander BP, Zhan X, Noblett D, Stamova B, Liu D (2014) microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One 9(6):e99283-e
Kim Y, Giusti-Rodriguez P, Crowley JJ, Bryois J, Nonneman RJ, Ryan AK et al (2018) Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects. Mol Psychiatry 23(3):708–712
Kim SH, Nairn AC, Cairns N, Lubec G (2001) Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer’s disease. J Neural Transm Suppl 61:263–272
Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11(4):441–450
Kuehner JN, Bruggeman EC, Wen Z, Yao B (2019) Epigenetic regulations in neuropsychiatric disorders. Front Gen 10(268)
Kutmon M, Kelder T, Mandaviya P, Evelo CT, Coort SL (2013) CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis. PloS One 8(12):e82160
Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9(1):1–13
Leung AKL, Sharp PA (2010) MicroRNA functions in stress responses. Mol Cell 40(2):205–215
Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF et al (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (london, England) 373(9659):234–239
Liu L, Zhao J, Chen Y, Feng R (2020) Metabolomics strategy assisted by transcriptomics analysis to identify biomarkers associated with schizophrenia. Anal Chim Acta 1140:18–29
Liu S, Zhao L, Zhang L, Qiao L, Gao S (2021) Downregulation of miR-574-5p inhibits HK-2 cell viability and predicts the onset of acute kidney injury in sepsis patients. Ren Fail 43(1):942–948
Lin Z, Chen M, Wan Y, Lei L, Ruan H (2020) miR-574-5p targets FOXN3 to regulate the invasion of nasopharyngeal carcinoma cells via Wnt/β-catenin pathway. Technol Cancer Res Treat 19:1533033820971659
Li J, Tiwari A, Mirzakhani H, Wang AL, Kho AT, McGeachie MJ et al (2021a) Circulating microRNA: incident asthma prediction and vitamin D effect modification. J Pers Med 11(4):307
Li W, Song Z, Jia N, Zhang C, Gao W, Wang L (2021b) microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16. In Vitro Cell Dev Biol Anim 57(7):715–725
Li F, Lo TY, Miles L, Wang Q, Noristani HN, Li D et al (2021c) The Atr-Chek1 pathway inhibits axon regeneration in response to piezo-dependent mechanosensation. Nat Commun 12(1):3845
Maes OC, An J, Sarojini H, Wang E (2008) Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 129(9):534–541
Mäki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P et al (2005) Predictors of schizophrenia—a review. Br Med Bull 73–74(1):1–15
Maric NP, Svrakic DM (2012) Why schizophrenia genetics needs epigenetics: a review. Psychiatr Danub 24(1):2–18
Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R et al (2009) Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14(12):1083–1094
Nelson PT, Wang WX, Rajeev BW (2008) MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18(1):130–138
O’Donovan MC, Owen MJ (1999) Candidate-gene association studies of schizophrenia. Am J Hum Genet 65(3):587–592
Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S et al (2008) Functional organization of the transcriptome in human brain. Nat Neurosci 11(11):1271–1282
Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA et al (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8(2):R27
Pries L-K, Gülöksüz S, Kenis G (2017) DNA methylation in schizophrenia. In: Delgado-Morales R (ed) Neuroepigenomics in Aging and Disease. Springer International Publishing, Cham, pp 211–236
Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256):748–752
Radulescu E, Jaffe AE, Straub RE, Chen Q, Shin JH, Hyde TM et al (2020) Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry 25(4):791–804
Reitz C, Tokuhiro S, Clark LN, Conrad C, Vonsattel J-P, Hazrati L-N et al (2011) SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer’s disease risk. Ann Neurol 69(1):47–64
Richetto J, Meyer U (2021) Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol Psychiat 89(3):215–226
Seven M, Karatas OF, Duz MB, Ozen M (2014) The role of miRNAs in cancer: from pathogenesis to therapeutic implications. Future Oncol 10(6):1027–1048
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504
Sharma RP, Grayson DR, Gavin DP (2008) Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 98(1–3):111–117
Shen A, Tong X, Li H, Chu L, Jin X, Ma H et al (2021) TPPP3 inhibits the proliferation, invasion and migration of endometrial carcinoma targeted with miR-1827. Clin Exp Pharmacol Physiol 48(6):890–901
Shi W, Du J, Qi Y, Liang G, Wang T, Li S et al (2012) Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res 46(2):198–204
Smyth GK (2005) Limma: linear models for microarray data. Springer, Bioinformatics and computational biology solutions using R and Bioconductor, pp 397–420
Soleimani Zakeri NS, Pashazadeh S, MotieGhader H (2020) Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach. Sci Rep 10(1):12210
Starnawska A, Demontis D, McQuillin A, O’Brien NL, Staunstrup NH, Mors O et al (2016) Hypomethylation of FAM63B in bipolar disorder patients. Clin Epigenetics 8(1):52
Sun Y, Wang MJ, Cao XT, Liu WY, Chen HY, Ding XQ et al (2021) Expression of microRNAs in peripheral blood of patients with primary immune thrombocytopenia and its correlation with the imbalance of Th1/Th2 cell. Zhongguo Shi Yan Xue Ye Xue Za Zhi 29(5):1570–1576
Tang X, Tang G, Özcan S (2008) Role of microRNAs in diabetes. Biochim Et Biophys Acta (BBA)-Gene Reg Mech 1779(11):697–701
Taylor MA, Gaztanaga P, Abrams R (1974) Manic-depressive illness and acute schizophrenia: a clinical, family history, and treatment-response study. Am J Psychiatry 131(6):678–682
Treiber T, Treiber N, Meister G (2012) Regulation of microRNA biogenesis and function. Thromb Haemost 107(04):605–610
Torkamani A, Dean B, Schork NJ, Thomas EA (2010) Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res 20(4):403–412
Van Wijnen AJ, Van De Peppel J, Van Leeuwen JP, Lian JB, Stein GS, Westendorf JJ et al (2013) MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep 11(2):72–82
van Os J, Kapur S (2009a) Schizophrenia. Lancet (london, England) 374(9690):635–645
van Os J, Kapur S (2009b) Schizophrenia. The Lancet 374(9690):635–645
Wang F, Li Z, Zhao M, Ye W, Wu H, Liao Q et al (2021a) Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus. Gynecol Endocrinol 37(7):665–671
Wang J, Xie S, Liu J, Li T, Wang W, Xie Z (2021b) MicroRNA-4429 suppresses proliferation of prostate cancer cells by targeting distal-less homeobox 1 and inactivating the Wnt/β-catenin pathway. BMC Urol 21(1):40
Wang J, Lu M, Qiu C, Cui Q (2010) TransmiR: a transcription factor–microRNA regulation database. Nucleic Acid Res 38(suppl_1):D119-D122
Wen Y-D, Xia Z-W, Li D-J, Cheng Q, Zhao Q, Cao H (2020) Genetic profiles playing opposite roles of pathogenesis in schizophrenia and glioma. Journal of Oncology 2020:3656841
Wang Y, Gao R, Li J, Tang S, Li S, Tong Q et al (2020) Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis. Aging 12(10):9793–9806
Wu W, Wu D, Yan W, Wang Y, You J, Wan X et al (2021) Interferon-induced macrophage-derived exosomes mediate antiviral activity against hepatitis B virus through miR-574-5p. J Infect Dis 223(4):686–698
Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E et al (2013) Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep 29(1):169–176
Zhang Y, You X, Li S, Long Q, Zhu Y, Teng Z et al (2020) Peripheral blood leukocyte RNA-Seq identifies a set of genes related to abnormal psychomotor behavior characteristics in patients with schizophrenia. Medic Sci Moni: Int Med J Experiment Clin Res 26:e922426-e
Zhou Z, Zheng X, Mei X, Li W, Qi S, Deng Y et al (2021a) Hsa_circ_0080229 upregulates the expression of murine double minute-2 (MDM2) and promotes glioma tumorigenesis and invasion via the miR-1827 sponging mechanism. Ann Translat Med 9(9):762
Zhou S, Qian K, Yu S, Zhao Y, Shen Q, Li Y (2021b) MiR-4429 alleviates malignant behaviors of lung adenocarcioma through Wnt/β-catenin pathway. Cancer Biother Radiopharma
Zhu S, Peng W, Li X, Weng J, Zhang X, Guo J et al (2017) miR-1827 inhibits osteogenic differentiation by targeting IGF1 in MSMSCs. Sci Rep 7:46136
Funding
This article is the result of the findings of the research project 97542 that was approved and financed by Vice Chancellor for Research and Research and Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Author information
Authors and Affiliations
Contributions
Conceptualization: Yazdan Rahmati and Omran Davarinejad; computational analyses and experiments: Yazdan Rahmati, Sajad Najafi, and Hossein Zhaleh; writing manuscript: Yazdan Rahmati, Sajad Najafi, Farzaneh Golmohammadia, Farnaz Radmehra, Mostafa Alikhania, and Reza Heidari Moghadam; and supervision and finalization: Yazdan Rahmati.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
All patients gave their signed written informed consent letters. Medical Research and Ethical Committee of Kermanshah University of Medical Sciences (Kermanshah, Iran; registration no. IR.KUMS.REC.1397.490; grant number 97542) approved the study performed under ethical principles contained in the 7th and current (2013) editions of Helsinki Declaration.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Davarinejad, O., Najafi, S., Zhaleh, H. et al. MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia. J Mol Neurosci 72, 226–238 (2022). https://doi.org/10.1007/s12031-021-01945-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01945-0